Quantum Genomics US

Quantum Genomics US Biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases

Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure. Quantum Genomics is developing a new therapeutic approach based on BAPAI (Brain Aminopeptidase A Inhibition). This is the result of more than 20 years of academic research in the laboratories

of the Collège de France, INSERM, CNRS and the University of Paris Descartes. Quantum Genomics is listed on the Alternext market in Paris (ISIN code FR0011648971, Ticker ALQGC).

Adresse

Tour Montparnasse 33 Avenue Du Maine
Paris
75015

Téléphone

+33185347770

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Quantum Genomics US publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager

Type